Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy

Background: Postmortem studies have shown atrophy of the superior cerebellar peduncle (SCP) to distinguish progressive supranuclear palsy (PSP) from other neurodegenerative diseases. It is not clear whether MRI-based measurements can differentiate this relative atrophy of the SCP during life. Methods: Volumetric MRI was acquired prospectively in 53 subjects: 19 with PSP, 10 with multiple system atrophy (MSA), 12 with Parkinson disease (PD), and 12 healthy controls. SCP volume was assessed by detailed quantitative volumetric measurement and independently by blinded visual rating of SCP atrophy. Results: The mean SCP volume, corrected for total intracranial volume, was lower in patients with PSP than controls (p < 0.001), patients with MSA (p = 0.001), and patients with PD (p = 0.003). There was an overlap between individual SCP volume measurements in the PSP subjects and the other groups. Neuroradiologic rating correctly identified PSP cases based on the presence of SCP atrophy with a sensitivity of 74% and a specificity of 94%. Conclusions: The authors propose that together with other radiologic features of progressive supranuclear palsy (PSP) such as midbrain atrophy, a visual assessment of the superior cerebellar peduncle may help increase the clinical diagnostic accuracy in PSP.

[1]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[2]  I. McKeith,et al.  SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders , 2003, Movement disorders : official journal of the Movement Disorder Society.

[3]  M. Oda,et al.  Progressive supranuclear palsy: MRI and pathological findings , 1996, Neuroradiology.

[4]  S. Nakamura,et al.  Characteristic magnetic resonance imaging findings in Machado-Joseph disease. , 1998, Archives of neurology.

[5]  Nick C. Fox,et al.  Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates , 2004, NeuroImage.

[6]  F Lhermitte,et al.  Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease , 1986, Neurology.

[7]  S. Leurgans,et al.  Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale , 2000, Movement disorders : official journal of the Movement Disorder Society.

[8]  D W Dickson,et al.  Atrophy of superior cerebellar peduncle in progressive supranuclear palsy , 2003, Neurology.

[9]  G A Johnson,et al.  Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. , 1986, Radiology.

[10]  Nick C Fox,et al.  Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. , 2001, AJNR. American journal of neuroradiology.

[11]  E. Ciceri,et al.  Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. , 1994, Journal of neural transmission. Supplementum.

[12]  I Litvan,et al.  Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders , 1996, Journal of neuropathology and experimental neurology.

[13]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[14]  Andrew J. Lees,et al.  Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease , 2001, Neurology.

[15]  I Litvan,et al.  Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.

[16]  L Solymosi,et al.  Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. , 2001, Archives of neurology.

[17]  R I Grossman,et al.  Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes , 1989, Neurology.

[18]  Nick C Fox,et al.  Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. , 1997, Computer methods and programs in biomedicine.

[19]  Shigeo Murayama,et al.  Magnetic Resonance Imaging Findings of Machado–Joseph Disease: Histopathologic Correlation , 2003, Journal of computer assisted tomography.

[20]  F. Tison,et al.  Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.

[21]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[22]  P Soliveri,et al.  MR Imaging in Progressive Supranuclear Palsy and Shy‐Drager Syndrome , 1989, Journal of computer assisted tomography.

[23]  Y. Mano [Steele-Richardson-Olszewski syndrome]. , 1993, Nihon rinsho. Japanese journal of clinical medicine.

[24]  A. Rajput,et al.  Progressive Supranuclear Palsy , 2001, Drugs & aging.

[25]  S. Nakamura,et al.  Characteristic magnetic resonance imaging findings in spinocerebellar ataxia 6. , 1998, Archives of neurology.

[26]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.